Benefit-Risk Appraisal of Medicines
A Systematic Approach to Decision-making
Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company. Despite this there are very few tried and tested evaluative models currently available.The authors of this book have developed a new, pioneering tool for the assessment of benefits and risks for new medicines in development and their regulatory reviews. This model utilises a multi-criteria decision analysis which involves selecting, scoring and weighting key b…
Mehr
CHF 145.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Salek, Sam / Walker, Stuart
- ISBN: 978-0-470-06085-8
- EAN: 9780470060858
- Produktnummer: 2823482
- Verlag: John Wiley & Sons Inc
- Sprache: Englisch
- Erscheinungsjahr: 2009
- Seitenangabe: 304 S.
- Masse: H25.2 cm x B17.4 cm x D2.1 cm 670 g
- Gewicht: 670
- Sonstiges: Professional & Vocational
1 weiteres Werk von Filip Mussen:
Bewertungen
Anmelden